Price (delayed)
$15.29
Market cap
$711.95M
P/E Ratio
21.84
Dividend/share
$0.04
EPS
$0.7
Enterprise value
$853.43M
Relative Growth:
Rel. Growth:
58
Relative Strength:
Rel. Strength:
73
Relative Valuation:
Rel. Valuation:
71
Relative Profitability:
Rel. Profitability:
57
Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70
Highlights
CLB's net income is up by 23% year-on-year and by 8% since the previous quarter
Core Laboratories N V's EPS has increased by 21% YoY and by 8% from the previous quarter
The stock's price to earnings (P/E) is 49% less than its 5-year quarterly average of 44.3 but 6% more than its last 4 quarters average of 21.2
CLB's gross profit is down by 3.5% year-on-year but it is up by 2% since the previous quarter
The gross margin has decreased by 2.9% YoY
Key stats
What are the main financial stats of CLB
Market
Valuations
Earnings
Shares outstanding
46.56M
Market cap
$711.95M
Enterprise value
$853.43M
Price to earnings (P/E)
21.84
Price to book (P/B)
2.64
Price to sales (P/S)
1.37
PEG
1.06
EV/EBIT
15.75
EV/EBITDA
12.4
EV/Sales
1.65
Revenue
$517.5M
Gross profit
$103.23M
Operating income
$54.81M
Net income
$32.12M
EBIT
$54.2M
EBITDA
$68.85M
Free cash flow
$37.55M
Per share
Balance sheet
Liquidity
EPS
$0.7
EPS diluted
$0.7
Free cash flow per share
$0.81
Book value per share
$5.79
Revenue per share
$11.19
TBVPS
$10.49
Total assets
$591.36M
Total liabilities
$313.97M
Debt
$167.1M
Equity
$271.35M
Working capital
$131.17M
Debt to equity
0.62
Current ratio
2.37
Quick ratio
1.42
Net debt/EBITDA
2.05
Margins
Efficiency
Dividend
EBITDA margin
13.3%
Gross margin
19.9%
Net margin
6.2%
Operating margin
10.6%
Return on assets
5.4%
Return on equity
12.4%
Return on invested capital
10%
Return on capital employed
10.9%
Return on sales
10.5%
Dividend yield
0.26%
DPS
$0.04
Payout ratio
5.7%
CLB stock price
How has the Core Laboratories N V stock price performed over time
Intraday
-2.61%
1 week
-4.2%
1 month
23.51%
1 year
-29.25%
YTD
-11.67%
QTD
23.71%
Financial performance
How have Core Laboratories N V's revenue and profit performed over time
Revenue
$517.5M
Gross profit
$103.23M
Operating income
$54.81M
Net income
$32.12M
Gross margin
19.9%
Net margin
6.2%
CLB's net margin is up by 24% YoY and by 9% from the previous quarter
CLB's net income is up by 23% year-on-year and by 8% since the previous quarter
Core Laboratories N V's operating income has decreased by 7% YoY but it has increased by 2.1% QoQ
The operating margin has decreased by 6% YoY
Price vs fundamentals
How does CLB's price correlate with its fundamentals
Growth
What is Core Laboratories N V's growth rate over time
Valuation
What is Core Laboratories N V stock price valuation
P/E
21.84
P/B
2.64
P/S
1.37
EV/EBIT
15.75
EV/EBITDA
12.4
EV/Sales
1.65
The stock's price to earnings (P/E) is 49% less than its 5-year quarterly average of 44.3 but 6% more than its last 4 quarters average of 21.2
Core Laboratories N V's EPS has increased by 21% YoY and by 8% from the previous quarter
The P/B is 53% below the 5-year quarterly average of 5.8 but 4.2% above the last 4 quarters average of 2.6
CLB's equity is up by 8% YoY and by 3.9% from the previous quarter
CLB's price to sales (P/S) is 30% lower than its 5-year quarterly average of 2.0 but 8% higher than its last 4 quarters average of 1.3
Efficiency
How efficient is Core Laboratories N V business performance
The ROA has grown by 23% YoY and by 8% from the previous quarter
The return on equity rose by 12% year-on-year and by 7% since the previous quarter
Core Laboratories N V's ROS has decreased by 5% YoY
The return on invested capital is up by 3.1% since the previous quarter
Dividends
What is CLB's dividend history
DPS
$0.04
Dividend yield
0.26%
Payout ratio
5.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Core Laboratories N V financials performed over time
The total assets is 88% greater than the total liabilities
The total liabilities has decreased by 9% YoY and by 6% from the previous quarter
CLB's current ratio is down by 4.4% year-on-year but it is up by 4.4% since the previous quarter
CLB's debt is 38% less than its equity
The debt to equity has decreased by 21% YoY and by 9% QoQ
CLB's debt is down by 14% YoY and by 6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.